- Home
- »
- Pharmaceuticals
- »
-
Pharmacy Market Size, Share, Growth & Trends Report 2030GVR Report cover
![Pharmacy Market Size, Share & Trends Report]()
Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Retail Pharmacy, ePharmacy), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68039-701-1
- Number of Report Pages: 145
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2023
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Pharmacy Market Size & Trends
The global pharmacy market size was estimated at USD 1.26 trillion in 2023 and is expected to grow at a CAGR of 7.28% from 2024 to 2030. The growing demand for specialty drugs globally and increasing prescription drug expenditure in developed countries are expected to drive the growth of the market over the forecast period. In addition, the growing prevalence of chronic diseases, majorly due to changes in lifestyle and a rapidly aging population, are supplementing the market growth.
The growing demand for prescription medications is contributing to the industry's growth. As the demand for prescription drugs increases, pharmacies experience a surge in business due to the need for dispensing these medications. According to the National Health Service the current cost of an NHS prescription in England for 2024-2025 is USD 12.65 per item, an increase of USD 0.51 from the previous year. Prescription charges are usually reviewed annually. The cost has increased steadily in recent years, from USD 8.80 in 2015 - 2016 to USD 10.47 in 2024 - 2025.
Moreover, pharmacies are adopting digitalization programs to cater to the growing demand from consumers and provide improved accessibility to patients. For instance, CVS Health introduced a Digital Transformation program to personalize the healthcare experience using artificial intelligence, machine learning, data, and analytics. Moreover, in December 2021, the company entered into a partnership with Microsoft to scale up retail personalization and loyalty programs using advanced machine learning, powered by Azure. Such digitalization and automation strategies are anticipated to drive the growth in the industry during the forecast period.
Market Concentration & Characteristics
The industry is highly fragmented with the presence of many local and regional pharmacies. Furthermore, the degree of innovation is medium, and the level of M&A activities is high. The impact of regulations on the industry is high, while regional expansion is low. However, service expansion is low.
The degree of innovations in the industry is significant, driven by the integration of cutting-edge technologies such as Artificial Intelligence (AI). Furthermore, the COVID-19 pandemic has accelerated this shift towards digital healthcare solutions, with consumer trust in online medication purchases increasing significantly. The adoption of telehealth services, including telepharmacy, has surged, with patient adoption in the U.S. increasing from 11% in 2019 to 46% in 2024.
The industry's merger and acquisition activity has significantly increased in recent years. Key stakeholders are implementing strategies, such as mergers and acquisitions, to enhance their distribution channels and industry share. For instance, in June 2021, Medly Pharmacy acquired Pharmaca, a pharmacy chain, to expand its presence across thirty different markets.
The impact of regulations on the industry is significant. The FDA administers drug distribution and regulation, while state & local governments have some authority. Congress has a legislative mandate, while the FDA also creates and modifies regulations related to pharmacy practices. This activity aims to provide a concise overview of significant legislation and regulations in the field. Furthermore, the Prescription Drug Marketing Act ensures the quality of medications for American consumers by preventing adulteration, counterfeiting, misbranding, sub-potency, and expired drugs. It also regulates the reimportation of drugs and enhances the rigor in sales and distribution of pharmaceuticals.
Pharmacies are expanding their services to improve patient outcomes and increase profit and contribute to demand for the industry. For instance, in March 2022,Albertsons Companies introduced a new program that allows customers to buy over-the-counter medications using supplemental benefits in their stores. The program enabled customers to use prepaid cards that Medicare Advantage funds plans, healthcare providers, employer incentives, or local governments.
The industry is experiencing significant growth globally, with key regions showing promising expansion opportunities. Several companies are expanding their presence in different regions. For instance, CVS Health, a leading U.S. pharmacy retailer, has been growing its footprint across the country. In 2021, CVS operated over 9,900 retail locations and 1,100 walk-in medical clinics.
Product Insights
Based on product type, the prescription segment dominated the pharmacy market with the largest revenue share of 81.5% in 2023. The increasing demand for prescription drugs for therapies, such as diabetes, cardiovascular disease, respiratory diseases, antibiotics, blood disorders, and oncology, is driving the growth of the prescription segment. Furthermore, the rising prevalence of long-term health conditions and the expanding elderly demographic are fueling the need for prescription drugs.
According to the IDF Diabetes Atlas, 537 million adults were suffering from diabetes in 2021 globally. The number of adults suffering from diabetes is estimated to increase to 783 million by 2045. Almost 90% of older adults regularly take at least one prescription drug, with many taking multiple medications to manage chronic conditions. This growing need for prescription drugs, especially among the aging population, is expected to significantly drive the growth of the industry in the coming years.
However, the OTC segment is estimated to witness the fastest growth rate during the forecast period. The high growth is due to better cost savings compared to prescription drugs, consumer empowerment in managing minor ailments, a shift toward preventive healthcare, an expanding product range, consumer awareness & education, and the influence of online sales and e-commerce platforms. In addition, the increasing trend of self-medication and conversion of prescription medicines to OTC medications is expected to contribute to the growth of the segment over the forecast period. For instance, in March 2023, the U.S. FDA approved Narcan (4 mg), a naloxone hydrochloride nasal spray, for OTC use. It is the first-ever naloxone product approved to be used OTC.
Type Insights
The retail pharmacy segment held the highest revenue share of 55.3% in 2023. The increasing presence of chain pharmacies & independent pharmacies and the availability of medications in supermarkets & mass retailers in countries such as the UK & the U.S., is driving the growth of the segment. Large chains such as Boots, Walgreens, CVS Health, Lloyd, Shoppers Drug Mart, and Well Pharmacy have a significant presence in countries such as Canada, the U.S., Australia, the U.K., and Russia. This concentration of major retailers is promoting the growth of the segment.
ePharmacy is estimated to be the fastest-growing segment during the forecast period. In 2020, numerous Innovations such as telepharmacy, mobile apps for prescription ordering, medication reminders, and online consultations have improved efficiency and accessibility, enhanced the customer experience, and expected to drive the growth of the segment. ePharmacies experienced a rise in revenue growth due to the COVID-19 pandemic. For instance, during pandemic CVS Health has seen a significant increase in digital refills for specialty medications through its mobile apps. Online sales of Walgreen Boots Alliance U.K. increased by 15.2% in 2022. Moreover, increasing penetration of smartphones, the high adoption of digital technologies by the healthcare industry, and growing number of retailers introducing online channels are projected to contribute to the growth of the industry.
Regional Insights
North America dominated the market with a share of 53.3% in 2023. Growth can be attributed to the presence of large-scale multinational chains, such as Boots Walgreens, CVS Health, UnitedHealth Group, Cigna, Kroger, Walmart, and Rite Aid Corp. These players are leveraging diverse strategies and advance technologies to expand their presence and dominance. For instance, in March 2022, Rite Aid Corp. launched its Wellness + loyalty program, providing substantial savings and incentives to its valued customers.
U.S. Pharmacy Market Trends
The U.S. held the largest market share in 2023. Innovations in delivery methods and digital health technologies are enabling access to new and improved OTC and prescription drugs, further driving the growth. Furthermore, increasing demand for specialty drugs has influenced growth in drug utilization management services, such are prior authorization, step therapy, and quantity limits.
Europe Pharmacy Market Trends
Europe held a significant share in 2023. This growth is attributed to the increasing number of people with chronic diseases turning to online pharmacies for convenience and accessibility to medications, especially in rural areas.
The UK pharmacy market held a substantial revenue share in 2023. The imbalance of supply and demand, demographic changes, consolidation in the market, and a backlog of medical treatments are driving the demand for pharmacies in the UK. According to the Hutchings Consultants, the number of new buyers seeking to buy their own pharmacy increased by around 56.9% from March 2019/2020 to March 2020/2021.
The Germany pharmacy market held the largest share in Europe, in 2023. An aging population, increased demand for prescription drugs, and government regulations are expected to drive the growth of the market. ePharmacy has significantly impacted the market, making it easier for consumers to access a wider range of medications and healthcare products online. ePharmacies have gained a significant share, especially for non-urgent products such as weight loss or habit control.
Asia Pacific Pharmacy Market Trends
The Asia Pacific market is expected to experience the fastest growth in the coming years. The Asia-Pacific region is experiencing an aging population and a rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases. This demographic shift is driving increased demand for the market.
The pharmacy market in China dominated the Asia Pacific market in 2023 and is expected to sustain dominance during the forecast period. Regulations such as allowing medicines on the National Reimbursement Drug List to be sold and reimbursed at both hospitals and retail pharmacies, and the recent deregulation of online prescription drug sales, are contributing to the growth of the industry in the country.
India pharmacy market is expected to exhibit the fastest growth rate during the forecast period. Key pharmacies are rapidly expanding their service lines to include ePharmacies, which is expected to boost the demand for pharmacies in the country. For instance, in March 2021, Generic Aadhar, an Indian pharmacy retail chain, launched a mobile app to enable customers to purchase generic medications and have them delivered to their local store.
Latin America Pharmacy Market Trends
Latin America market growth can be attributed to the growing dominance of pharmacy chains in many countries, with a handful of retailers now operating over three-quarters of pharmacies in markets such as Chile, Colombia, and Peru. This consolidation has been driven by strategies such as wholly owned outlets, franchises, and cooperatives.
The pharmacy market in Brazil is expected to grow at significant rate over the forecast period, owing to the demographic changes, the expansion of retail chains, and government efforts to improve healthcare access.
MEA Pharmacy Market Trends
The MEA market is expected to witness lucrative growth due to the use of advanced technologies such as AI and mobile apps enhancing efficiency, security, and user engagement in the ePharmacy ecosystem. The launch of ePharmacy platforms, leveraging digital transformation and increased internet penetration to provide convenient access to healthcare products and services is expected to drive the growth of the industry over the forecast period.
Saudi Arabia pharmacy market is expected to experience the fastest growth rate over the forecast period. The adoption of technologies such as Electronic Health Records (EHRs), pharmacy automation devices, medication dispensing technologies, and ePharmacy platforms is improving the efficiency and accessibility of services contributing to the growth of the market.
Key Pharmacy Company Insights
Companies in the market are implementing diverse strategies such as partnerships, collaborations, mergers & acquisitions, and product development to expand their geographical footprint. CVS Health, Boots Walgreens, Walmart, and Rite Aid Corp. are some major players in the market.
Key Pharmacy Companies:
The following are the leading companies in the pharmacy market. These companies collectively hold the largest market share and dictate industry trends.
- CVS Health
- Boots Walgreens
- Cigna
- Walmart
- Kroger
- Rite Aid Corp.
- Lloyd Pharmacy
- Well Pharmacy
- Humana Pharmacy Solutions
- Matsumoto Kiyoshi
- Apollo Pharmacy
- MedPlusMart.com
Recent Developments
-
In January 2024, Kroger extended its partnership with Centene Corporation's pharmacy network. This extension aimed to provide patients with increased opportunities to save on essential prescriptions. The agreement ensured continued access to the Kroger Family of Pharmacies for approximately 700,000 Centene members in 2024.
-
In April 2023, Rite Aid Corp launched a new three Rite Aid Pharmacies in Craigsville, Greenville, and Scottsville, Virginia. This initiative was part of a pilot program aimed at enhancing access to services in “pharmacy deserts” and underserved communities.
-
In February 2022, Medicure Inc. subsidiary Marley Drug Pharmacy in the U.S. introduced its national direct-to-consumer ePharmacy platform, which allows Americans to purchase FDA-approved medications at reduced prices and receive home delivery across all 50 states.
-
In January 2021, AmerisourceBergen and Walgreens Boots Alliance established a strategic partnership. AmerisourceBergen acquired Walgreens Boots Alliance's Healthcare Business, allowing Walgreens Boots Alliance to enhance its emphasis on expanding its retail operations. This collaboration involves extending and broadening their commercial agreements.
Pharmacy Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 1.35 trillion
Revenue forecast in 2030
USD 2.06 trillion
Growth rate
CAGR of 7.28% from 2024 to 2030
Actual data
2018 - 2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million/billion and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, type, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
CVS Health; Boots Walgreens; Cigna; Walmart; Kroger; Rite Aid Corp.; Lloyd Pharmacy; Well Pharmacy; Humana Pharmacy Solutions; Matsumoto Kiyoshi; Apollo Pharmacy; MedPlusMart.com.
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Pharmacy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmacy market report based on product, type, and region.
-
Product Outlook (Revenue, USD Billion, 2018 - 2030)
-
Prescription
-
OTC
-
-
Type Outlook (Revenue, USD Billion, 2018 - 2030)
-
Hospital Pharmacy
-
Retail Pharmacy
-
Chain
-
Independent
-
Others
-
-
ePharmacy
-
Others
-
-
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Denmark
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Argentina
-
-
MEA
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global pharmacy market size was estimated at USD 1.26 trillion in 2023 and is expected to reach USD 1.35 trillion in 2024.
b. The global pharmacy market is expected to grow at a compound annual growth rate of 7.28% from 2024 to 2030 to reach USD 2.06 trillion by 2030.
b. North America dominated the pharmacy market and accounted for the largest revenue share of 53.30% in 2023. This growth can be attributed to factors such as the aging population, increasing demand for prescription medications, and the rise in the adoption of e-pharmacy services.
b. Some key players operating in the pharmacy market include CVS Health; Boots Walgreens; Cigna; Walmart; Kroger; Rite Aid Corp.; Lloyd Pharmacy; Well Pharmacy; Humana Pharmacy Solutions; Matsumoto Kiyoshi, Apollo Pharmacy, MedPlusMart.com.
b. Key factors that are driving the pharmacy market growth include increasing demand for specialty drugs, growing adoption of pharmacy, and increasing adoption of digitalization by retail pharmacies.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.8.2. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing prevalence of chronic diseases
3.3.1.2. Expanding health insurance coverage
3.3.1.3. Technological advancement
3.3.1.4. Increasing demand for specialty drugs
3.3.2. Market Restraint Analysis
3.3.2.1. Product Recalls and Lawsuits
3.3.2.2. Lack of trained staff
3.3.3. Industry Opportunities
3.3.4. Industry Challenges
3.4. Business Environment Analysis
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Pharmacy Market: Product Movement Analysis
4.2. Pharmacy Product Market: Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2023 & 2030
4.4. Global Pharmacy Market Estimates & Forecast, by Product
4.5. Prescription
4.5.1. Prescription market, 2018 - 2030 (USD Billion)
4.6. OTC
4.6.1. OTC market, 2018 - 2030 (USD Billion)
Chapter 5. Type Business Analysis
5.1. Pharmacy Market: Type Movement Analysis
5.2. Type Market: Segment Dashboard
5.3. Type Movement & Market Share Analysis, 2023 & 2030
5.4. Global Pharmacy Market Estimates & Forecast, by Type
5.5. Hospital Pharmacy
5.5.1. Hospital Pharmacy market, 2018 - 2030 (USD Billion)
5.6. Retail Pharmacy
5.6.1. Retail Pharmacy market, 2018 - 2030 (USD Billion)
5.6.2. Chain
5.6.2.1. Chain Pharmacy market, 2018 - 2030 (USD Billion)
5.6.3. Independent pharmacy
5.6.3.1. Independent pharmacy market, 2018 - 2030 (USD Billion)
5.6.4. Others
5.6.4.1. Others market, 2018 - 2030 (USD Billion)
5.7. ePharmacy
5.7.1. ePharmacy market, 2018 - 2030 (USD Billion)
5.8. Others
5.8.1. Others market, 2018 - 2030 (USD Billion)
Chapter 6. Regional Business Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. North America Pharmacy Market, 2018 - 2030 (USD Billion)
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. U.S. pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Canada pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive scenario
6.5.4.4. Mexico pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
6.6. Europe
6.6.1. Europe Pharmacy Market, 2018 - 2030 (USD Billion)
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. UK pharmacy market estimates & forecast,, 2018 - 2030 (USD Billion)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. Germany pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. France pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Italy pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Spain pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Sweden pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Norway pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework
6.6.9.3. Competitive scenario
6.6.9.4. Denmark pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7. Asia Pacific
6.7.1. Asia Pacific Pharmacy Market, 2018 - 2030 (USD Billion)
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. Japan pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. China pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. India pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. Australia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Thailand pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.7.7. South Korea
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework
6.7.7.3. Competitive scenario
6.7.7.4. South Korea pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.8. Latin America
6.8.1. Latin America Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Brazil pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. Argentina pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.9. MEA
6.9.1. MEA Pharmacy Market Estimates & Forecast, 2018 - 2030 (USD Billion)
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. South Africa pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. UAE pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait pharmacy market estimates & forecast, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. Expansion
7.2.2. Merger & Acquisition
7.2.3. New Service Launch
7.2.4. Partnership/Collaborations
7.2.5. Others
7.3. Company market position analysis
7.4. Company Profiles/Listing
7.4.1. CVS Health
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Boots Walgreens
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Cigna
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Walmart
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Kroger
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Rite Aid Corporation
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Lloyd Pharmacy
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Well Pharmacy
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.8.5. Strategic Initiatives
7.4.9. Humana Pharmacy Solutions
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Matsumoto Kiyoshi
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Apollo Pharmacy
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Service Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. MedPlusMart.com.
7.4.12.1. Overview
7.4.12.2. Financial Performance
7.4.12.3. Service Benchmarking
7.4.12.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 4 Global pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 5 Global pharmacy market, by region, 2018 - 2030 (USD Billion)
Table 6 North America pharmacy market, by country, 2018 - 2030 (USD Billion)
Table 7 North America pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 8 North America pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 9 U.S.pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 10 U.S pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 11 Canada pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 12 Canada pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 13 Mexico pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 14 Mexico pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 15 Europe pharmacy market, by country, 2018 - 2030 (USD Billion)
Table 16 Europe pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 17 Europe pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 18 UK pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 19 UK pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 20 Germany pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 21 Germany pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 22 France pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 23 France pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 24 Italy pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 25 Italy pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 26 Spain pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 27 Spain pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 28 Sweden pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 29 Sweden pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 30 Norway pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 31 Norway pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 32 Denmark pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 33 Denmark pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 34 Asia Pacific pharmacy market, by country, 2018 - 2030 (USD Billion)
Table 35 Asia Pacific pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 36 Asia Pacific pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 37 Japan pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 38 Japan pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 39 China pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 40 China pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 41 India pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 42 India pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 43 Australia pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 44 Australia pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 45 Thailand pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 46 Thailand pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 47 South Korea pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 48 South Korea pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 49 Latin America pharmacy market, by country, 2018 - 2030 (USD Billion)
Table 50 Latin America pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 51 Latin America pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 52 Brazil pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 53 Brazil pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 54 Argentina pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 55 Argentina pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 56 Middle East & Africa pharmacy market, by country, 2018 - 2030 (USD Billion)
Table 57 Middle East & Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 58 Middle East & Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 59 South Africa pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 60 South Africa pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 61 Saudi Arabia pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 62 Saudi Arabia pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 63 UAE pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 64 UAE pharmacy market, by type, 2018 - 2030 (USD Billion)
Table 65 Kuwait pharmacy market, by product, 2018 - 2030 (USD Billion)
Table 66 Kuwait pharmacy market, by type, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Pharmacy market segmentation
Fig. 3 Market research process
Fig. 4 Data triangulation techniques
Fig. 5 Primary research pattern
Fig. 6 Market research approaches
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD modelling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Market snapshot
Fig. 11 Market segmentation
Fig. 12 Competitive landscape
Fig. 13 Global pharmacy market lineage outlook
Fig. 14 Pharmacy market dynamics
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Pharmacy market: Porter’s five forces analysis
Fig. 18 Pharmacy market: PESTLE analysis
Fig. 19 Pharmacy market product outlook: Segment dashboard
Fig. 20 Pharmacy market: Product movement & market share analysis, 2023 & 2030
Fig. 21 Prescription market, 2018 - 2030 (USD Million)
Fig. 22 OTC market, 2018 - 2030 (USD Million)
Fig. 23 Pharmacy market type outlook: Segment dashboard)
Fig. 24 Pharmacy market: type movement & market share analysis, 2023 & 2030
Fig. 25 Hospital pharmacy market, 2018 - 2030 (USD Billion)
Fig. 26 Retail pharmacy market, 2018 - 2030 (USD Billion)
Fig. 27 Chain pharmacy market, 2018 - 2030 (USD Billion)
Fig. 28 Independent pharmacy market, 2018 - 2030 (USD Billion)
Fig. 29 Other retail pharmacy market, 2018 - 2030 (USD Billion)
Fig. 30 ePharmacy market, 2018 - 2030 (USD Billion)
Fig. 31 Other pharmacy market, 2018 - 2030 (USD Billion)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 North America pharmacy market, 2018 - 2030 (USD Billion)
Fig. 34 U.S key country dynamics
Fig. 35 U.S pharmacy market, 2018 - 2030 (USD Billion)
Fig. 36 Canada key country dynamics
Fig. 37 Canada pharmacy market, 2018 - 2030 (USD Billion)
Fig. 38 Mexico key country dynamic
Fig. 39 Mexico pharmacy market, 2018 - 2030 (USD Billion)
Fig. 40 Europe pharmacy market, 2017 - 2030 (USD Billion)
Fig. 41 UK key country dynamic
Fig. 42 UK pharmacy market, 2018 - 2030 (USD Billion)
Fig. 43 Germany key country dynamic
Fig. 44 Germany pharmacy market, 2018 - 2030 (USD Billion)
Fig. 45 France key country dynamic
Fig. 46 France pharmacy market, 2018 - 2030 (USD Billion)
Fig. 47 Italy key country dynamic
Fig. 48 Italy pharmacy market, 2018 - 2030 (USD Billion)
Fig. 49 Spain key country dynamic
Fig. 50 Spain pharmacy market, 2018 - 2030 (USD Billion)
Fig. 51 Denmark key country dynamic
Fig. 52 Denmark pharmacy market, 2018 - 2030 (USD Billion)
Fig. 53 Sweden key country dynamic
Fig. 54 Sweden pharmacy market, 2018 - 2030 (USD Billion)
Fig. 55 Norway key country dynamic
Fig. 56 Norway pharmacy market, 2018 - 2030 (USD Billion)
Fig. 57 Asia Pacific pharmacy market, 2018 - 2030 (USD Billion)
Fig. 58 China key country dynamic
Fig. 59 China pharmacy market, 2018 - 2030 (USD Billion)
Fig. 60 Japan key country dynamic
Fig. 61 Japan pharmacy market, 2018 - 2030 (USD Billion)
Fig. 62 India key country dynamic
Fig. 63 India pharmacy market, 2018 - 2030 (USD Billion)
Fig. 64 South Korea key country dynamic
Fig. 65 South Korea pharmacy market, 2018 - 2030 (USD Billion)
Fig. 66 Australia key country dynamic
Fig. 67 Australia pharmacy market, 2018 - 2030 (USD Billion)
Fig. 68 Thailand key country dynamic
Fig. 69 Thailand pharmacy market, 2018 - 2030 (USD Billion)
Fig. 70 Latin America pharmacy market, 2018 - 2030 (USD Billion)
Fig. 71 Brazil key country dynamic
Fig. 72 Brazil pharmacy market, 2018 - 2030 (USD Billion)
Fig. 73 Argentina key country dynamic
Fig. 74 Argentina pharmacy market, 2018 - 2030 (USD Billion)
Fig. 75 MEA pharmacy market, 2018 - 2030 (USD Billion)
Fig. 76 South Africa key country dynamic
Fig. 77 South Africa pharmacy market, 2018 - 2030 (USD Billion)
Fig. 78 Saudi Arabia key country dynamic
Fig. 79 Saudi Arabia pharmacy market, 2018 - 2030 (USD Billion)
Fig. 80 UAE key country dynamic
Fig. 81 UAE pharmacy market, 2018 - 2030 (USD Billion)
Fig. 82 Kuwait key country dynamic
Fig. 83 Kuwait pharmacy market, 2018 - 2030 (USD Billion)
Fig. 84 Company categorization
Fig. 85 Company market position analysis
Fig. 86 Strategic frameworkMarket Segmentation
- Pharmacy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Prescription
- OTC
- Pharmacy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Pharmacy Regional Outlook (USD Million, 2018 - 2030)
- North America
- North America Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- North America Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- U.S.
- U.S. Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- U.S. Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- U.S. Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Canada
- Canada Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Canada Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Canada Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Mexico
- Mexico Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Mexico Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Mexico Pharmacy Market, By Product (USD Million, 2018 - 2030)
- North America Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Europe
- Europe Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Europe Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- UK
- UK Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- UK Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- UK Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Germany
- Germany Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Germany Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Germany Pharmacy Market, By Product (USD Million, 2018 - 2030)
- France
- France Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- France Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- France Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Italy
- Italy Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Italy Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Italy Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Spain
- Spain Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Spain Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Spain Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Sweden
- Sweden Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Sweden Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Sweden Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Denmark
- Denmark Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Denmark Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Denmark Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Norway
- Norway Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Norway Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Norway Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Europe Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Asia Pacific
- Asia Pacific Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Asia Pacific Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Japan
- Japan Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Japan Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Japan Pharmacy Market, By Product (USD Million, 2018 - 2030)
- China
- China Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- China Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- China Pharmacy Market, By Product (USD Million, 2018 - 2030)
- India
- India Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- India Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- India Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Australia
- Australia Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Australia Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Australia Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Thailand
- Thailand Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Thailand Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Thailand Pharmacy Market, By Product (USD Million, 2018 - 2030)
- South Korea
- South Korea Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- South Korea Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- South Korea Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Asia Pacific Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Latin America
- Latin America Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Latin America Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Brazil
- Brazil Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Brazil Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Brazil Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Argentina
- Argentina Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Argentina Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Argentina Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Latin America Pharmacy Market, By Product (USD Million, 2018 - 2030)
- MEA
- MEA Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- MEA Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- South Africa
- South Africa Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- South Africa Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- South Africa Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Saudi Arabia
- Saudi Arabia Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Saudi Arabia Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Saudi Arabia Pharmacy Market, By Product (USD Million, 2018 - 2030)
- UAE
- UAE Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- UAE Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- UAE Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Kuwait
- Kuwait Pharmacy Market, By Product (USD Million, 2018 - 2030)
- Prescription
- OTC
- Kuwait Pharmacy Market, By Type (USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Chain
- Independent
- Others
- ePharmacy
- Others
- Kuwait Pharmacy Market, By Product (USD Million, 2018 - 2030)
- MEA Pharmacy Market, By Product (USD Million, 2018 - 2030)
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
Research Methodology
A three-pronged approach was followed for deducing the pharmacy market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmacy market to gather the most reliable and current information possible.
-
We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
-
We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
-
We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
-
We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
-
We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmacy market data depending on the type of information we’re trying to uncover in our research.
-
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
-
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
-
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
-
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
-
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
-
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
-
This step also entails the finalization of the report scope and data representation pattern.
-
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
Pharmacy Market Categorization:
The pharmacy market was categorized into three segments, namely product type (Prescription, OTC), pharmacy type (Hospital, Retail, ePharmacy), and regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Segment Market Methodology:
The pharmacy market was segmented into product type, pharmacy type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Market research approaches: Bottom-up
-
Demand estimation of each product across countries/regions summed up to from the total market.
-
Variable analysis for demand forecast.
-
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
-
Primary interviews for data revalidation and insight collection.
Market research approaches: Top-down
-
Used extensively for new product forecasting or analyzing penetration levels.
-
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
-
Primary interviews and vendor-based primary research for variable impact analysis.
Market research approaches: Combined
-
This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.
Regional Market Methodology:
The pharmacy market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into eighteen countries, namely, the U.S.; Canada; the UK; Germany; France; Spain; Italy; Russia; Japan; China; Australia; India; Brazil; Mexico; Argentina; South Africa; UAE; Saudi Arabia.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
Pharmacy market companies & financials:
The pharmacy market was analyzed via companies operating in the sector. Key market players analyzed include CVS Health; Boots Walgreens; Cigna; Walmart; Kroger; Rite Aid Corp.; Lloyd Pharmacy; Well Pharmacy; Humana Pharmacy Solutions; Matsumoto Kiyoshi
Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions.
Value chain-based sizing & forecasting
Supply Side Estimates
-
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
-
Segment revenue determination via variable analysis and penetration modeling.
-
Competitive benchmarking to identify market leaders and their collective revenue shares.
-
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
-
Identifying parent markets and ancillary markets
-
Segment penetration analysis to obtain pertinent
-
revenue/volume
-
Heuristic forecasting with the help of subject matter experts
-
Forecasting via variable analysis
Pharmacy Market Report Objectives:
-
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
-
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
-
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
Pharmacy Market Report Assumptions:
-
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
-
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
-
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
-
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
-
Inflation has not been accounted for to estimate and forecast the market.
-
Numbers may not add up due to rounding off.
-
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
-
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
-
Latin America includes Central American countries and the South American continent
-
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
Primary Research
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
-
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
-
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
![gvr icn]()
GET A FREE SAMPLE
![gvr icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
